Adagene Inc
Adagene Inc
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver) | Advanced Liver Cancers | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-03 | NCT04524871 | |
| Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Active, not recruiting | Phase 1 | 2026-01-08 | NCT05614258 | |
| ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-01-07 | NCT05405595 | |
| Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2025-07-25 | NCT06846268 | |
| Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-07-25 | NCT05491083 | |
| A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer | Advanced Solid Tumor; HER2-negative Breast Cancer | Active, not recruiting | Phase 1 / Phase 2 | 2025-07-25 | NCT05275777 |